ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX)
| CAPS Rating |
|
|---|---|
| Open | $0.73 |
| Previous Close | $0.72 |
| Daily Range | $0.68 - $0.73 |
| 52-Week Range | $0.56 - $4.21 |
| Market Cap | $18.92M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 598,256 |
| Average Daily Volume | 0 |
ANX
VS S&P 500 (SPY)
How do you think ANX will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ANX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ANX News and Commentary
- Zacks #1 Rank Additions for Monday - Tale of the Tape – NASDAQ
- Blue Horseshoe - Or Someone - Likes Anaconda Mining; Shares Pop 20% After Selling Iron Ore Assets – NASDAQ
- Zacks #1 Rank Additions for Friday - Tale of the Tape – NASDAQ
- The Big Bet on YM BioSciences – The Motley Fool
- Speedy in Seattle – The Motley Fool
- 5 of Last Week's Biggest Losers – The Motley Fool
- Aeterna Zentaris: Out of Sight, Out of Mind – The Motley Fool
- Adventrx Plunges Almost 60% on Botched Drug Study – Minyanville
- The Big Bet on ADVENTRX Pharmaceuticals – The Motley Fool
- Top Biotech Picks by Hedge Fund and Mutual Fund Gurus Concentrated in the Sector – SeekingAlpha
- Adventrx Poised for Run-Up Before FDA Decision – SeekingAlpha
- AdventRx: Safe Biotech With Upcoming Catalysts That May Boost It More – SeekingAlpha
- Expect Adventrx Pharma Shares to Fall Following Two Announcements – SeekingAlpha
- Arena joins the GBMB – Blog at The Motley Fool
- What are America's investing legends buying? – CNN Money
- 13-F Filing: Q/Q Comparison of Carl Icahn's Portfolio Holdings – SeekingAlpha
- UPDATE: Icahn Increases Exposure To Energy Companies In 2Q – SmartMoney
- Icahn Increases Exposure To Energy Companies In 2Q – SmartMoney
- ADVENTRX Pharmaceuticals: Primed to Jump or Drop? – SeekingAlpha
- Adventrx Pharma Sets Out to Improve Current Cancer Drugs – SeekingAlpha
RSS Headlines
Fool UK
